Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

El Paso, Texas


Purpose:

This study evaluates the safety and efficacy of brimonidine 0.2%/timolol 0.5% fixed combination ophthalmic solution compared with concurrent brimonidine 0.2% and timolol ophthalmic solutions


Criteria:

Inclusion Criteria: - Diagnosis of ocular hypertension or glaucoma - Patient requires IOP-lowering therapy in both eyes Exclusion Criteria: - Uncontrolled medical conditions - Contraindication to β-adrenoceptor antagonist therapy or brimonidine therapy


NCT ID:

NCT00652106


Primary Contact:

Study Director
Medical Director
Allergan


Backup Contact:

N/A


Location Contact:

El Paso, Texas
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.